Challenging economic conditions have been hurting life sciences-related investment activity across the Golden Triangle markets so far this year, according to Savills. The consultancy recorded £320m of assets traded or under offer in the first six months of 2023, down
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
Register
Find Out More